Milovan V Dimitrijevic1, Nada R Tomanovic2, Snezana D Jesic3, Nenad A Arsovic3, Aleksandar L J Mircic4, Aleksandar M Krstic5. 1. 1)Faculty of Medicine, University of Belgrade, Serbia. 2)Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Serbia. drmilova@yahoo.com; milovan.dimitrijevic@kcs.ac.rs. 2. 1)Faculty of Medicine, University of Belgrade, Serbia. 3)Institute of Pathology, Faculty of Medicine, University of Belgrade, Serbia. 3. 1)Faculty of Medicine, University of Belgrade, Serbia. 2)Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Serbia. 4. 1)Faculty of Medicine, University of Belgrade, Serbia. 4)Institute of Histology, Faculty of Medicine, University of Belgrade, Serbia. 5. 2)Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Serbia.
Abstract
INTRODUCTION: Epithelial-myoepithelial carcinoma is a low-grade malignant salivary gland neoplasm with a biphasic cell population that encompasses around 1% of all salivary neoplasms. METHOD: We present different cases of epithelial-myoepithelial carcinoma, with special emphasis on histopathology, differential diagnosis, relevant prognostic factors and follow-up. RESULT: This study included 8 patients who were diagnosed with epithelial-myoepithelial carcinoma and treated surgically including a follow-up period of at least 19 months. CONCLUSION: Clinical and histopathological characteristics of these rare tumors are extremely valuable for accurate diagnosis and further therapy planning.
INTRODUCTION:Epithelial-myoepithelial carcinoma is a low-grade malignant salivary gland neoplasm with a biphasic cell population that encompasses around 1% of all salivary neoplasms. METHOD: We present different cases of epithelial-myoepithelial carcinoma, with special emphasis on histopathology, differential diagnosis, relevant prognostic factors and follow-up. RESULT: This study included 8 patients who were diagnosed with epithelial-myoepithelial carcinoma and treated surgically including a follow-up period of at least 19 months. CONCLUSION: Clinical and histopathological characteristics of these rare tumors are extremely valuable for accurate diagnosis and further therapy planning.